Table 1.
Demographic and clinical data of patients with bulimia nervosa (BN) and healthy women (HW) participants.
| BN |
HW |
P-value | |||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Range | Mean | SD | Range | ||
| Number of participants (n) | 18 | 18 | |||||
| Age (years) | 25 | 5.63 | (18.6–36.3) | 27.09 | 5.69 | (20.7–36.4) | 0.285a |
| Education (years) | 13.89 | 1.94 | (11–18) | 14.56 | 1.04 | (12–16) | 0.211a |
| Duration of illness (years) | 3.25 | 3.41 | (0.6–6.5) | – | – | – | – |
| BMI (kg/m2) | 20.21 | 1.62 | (18.2–23.7) | 20.51 | 1.44 | (18.8–22.8) | 0.55a |
| Handedness (L/R; n) | 1/17 | 1/17 | |||||
| EDE-Qg | 4.29 | 1.11 | 1.31 | 0.71 | <0.001b | ||
| EDE-Qr | 4.12 | 1.56 | 0.6 | 0.62 | <0.001b | ||
| EDE-Qe | 3.94 | 1.23 | 0.67 | 0.57 | <0.001b | ||
| EDE-Qw | 4.5 | 1.13 | 1.74 | 1.16 | <0.001b | ||
| EDE-Qs | 4.58 | 1.23 | 2.17 | 1.21 | <0.001b | ||
| BITE-ss | 13.17 | 4.94 | 1.44 | 0.98 | <0.001b | ||
| BITE-sas | 24.44 | 3.05 | 6.56 | 4.2 | <0.001b | ||
| PHQ-9 | 12.83 | 5.37 | 4.56 | 3.2 | <0.001b | ||
| GAD-7 | 8.39 | 5.07 | 4.78 | 3.26 | 0.022b | ||
| Comorbidities (n) | |||||||
| Major depressive disorder | 4 | – | |||||
| Medication (n) | |||||||
| SSRIs | 2 | – | |||||
BMI, body mass index; BITE, Bulimic Investigatory Test, Edinburgh; BITE-sas, the symptom assessment scale of BITE; BITE-ss, the severity scale of BITE; EDE-Q, Eating Disorders Examination Questionnaire; EDE-Qe, eating concern; EDE-Qg, global score, the average of the four subscale scores; EDE-Qr, restricting; EDE-Qs, shape concern; EDE-Qw, weight concern; GAD-7, Generalized Anxiety Disorder scale; PHQ-9, Patient Health Questionnaire; SSRIs, selective serotonin reuptake inhibitors.
aTwo-sample t-tests.
bMann–Whitney U tests.